Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Clough

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancer|July 24, 2001
Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 casesA Vincent-Salomon, M Carton, B Zafrani, et al.
The British Journal of Dermatology|August 18, 2012
Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depthL J Titus, K Clough-Gorr, T A Mackenzie, et al.
Radiation Research|August 24, 1999
Histopathological and cellular studies of a case of cutaneous radiation syndrome after accidental chronic exposure to a cesium sourceM C Vozenin-Brotons, N Gault, V Sivan, et al.
The British Journal of Surgery|April 13, 2017
Quality of life after mastectomy with or without immediate breast reconstructionJ Dauplat, F Kwiatkowski, P Rouanet, et al.
International Journal of Cancer|March 12, 1998
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancerS Rozan, A Vincent-Salomon, B Zafrani, et al.
Human Antibodies|July 16, 1999
A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1M D Thomas, K Clough, M D Melamed, et al.
Cancer|June 20, 2001
Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter studyY Ansquer, E Leblanc, K Clough, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2000
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapyA Vincent-Salomon, M Carton, P Freneaux, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer|July 24, 2001
Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 casesA Vincent-Salomon, M Carton, B Zafrani, et al.
The British Journal of Dermatology|August 18, 2012
Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depthL J Titus, K Clough-Gorr, T A Mackenzie, et al.
Radiation Research|August 24, 1999
Histopathological and cellular studies of a case of cutaneous radiation syndrome after accidental chronic exposure to a cesium sourceM C Vozenin-Brotons, N Gault, V Sivan, et al.
The British Journal of Surgery|April 13, 2017
Quality of life after mastectomy with or without immediate breast reconstructionJ Dauplat, F Kwiatkowski, P Rouanet, et al.
International Journal of Cancer|March 12, 1998
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancerS Rozan, A Vincent-Salomon, B Zafrani, et al.
Human Antibodies|July 16, 1999
A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1M D Thomas, K Clough, M D Melamed, et al.
Cancer|June 20, 2001
Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter studyY Ansquer, E Leblanc, K Clough, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2000
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapyA Vincent-Salomon, M Carton, P Freneaux, et al.
Pageof 3